Investors - MM+M - Medical Marketing and Media

Investors

All articles by Investors

Publicis Groupe holds sale talks with private equity investor
Publicis Groupe holds sale talks with private equity investor
Gideon Spanier
January 8, 2021
12:20 pm

Discussions have taken place in recent months.

Purohit venture arm seeks to back biotech start-ups through ‘service as currency’ model
Purohit venture arm seeks to back biotech start-ups through ‘service as currency’ model
Marc Iskowitz
December 9, 2020
4:06 pm

The women-led investment firm fills a niche between a traditional venture fund and a commercialization agency, founder says.

Five things for pharma marketers to know: Wednesday, January 24, 2018
Five things for pharma marketers to know: Wednesday, January 24, 2018
Virginia Lau
January 24, 2018
3:00 pm

Novartis sees single-digit growth with new CEO; J&J takes $13.6b charge in the wake of the new tax law; New York City invests in biotech

Five things for pharma marketers to know: Wednesday, January 17, 2018
Five things for pharma marketers to know: Wednesday, January 17, 2018
Virginia Lau
January 17, 2018
3:20 pm

Celgene reportedly in talks to buy Juno; Novartis’ Kymriah receives fast-track reviews in U.S. and Europe; BI’s Gilotrif gets expanded approval in lung cancer

Stagwell’s Penn says digital marketing agencies are ‘undervalued’ as he eyes more M&A
Stagwell’s Penn says digital marketing agencies are ‘undervalued’ as he eyes more M&A
Gideon Spanier
January 11, 2018
8:10 pm

The founder of Stagwell has claimed digital marketing agencies are undervalued because investors still fail to appreciate how much digital communications and e-commerce are going to transform the economy.

Five things for pharma marketers to know: Friday, January 5, 2018
Five things for pharma marketers to know: Friday, January 5, 2018
Virginia Lau
January 5, 2018
3:25 pm

Takeda announces deals worth more than $1 billion; biotech and pharma investments reached $10.5 billion in 2017; prescriptions for nerve pain on the rise

Five things for pharma marketers to know: Wednesday, December 20, 2017
Five things for pharma marketers to know: Wednesday, December 20, 2017
Virginia Lau
December 20, 2017
2:20 pm

Tax bill could lead pharma to move overseas; global pharma sales increased 45% in nine years; FDA OKs first gene therapy for rare retinal disease

Five things for pharma marketers to know: Tuesday, December 5, 2017
Five things for pharma marketers to know: Tuesday, December 5, 2017
Virginia Lau
December 5, 2017
3:30 pm

Botox-like wrinkle-reducer shows positive results in trials; investors double down on fertility; few websites transparent about pricing, study finds

Five things for pharma marketers to know: Tuesday, October 31, 2017
Five things for pharma marketers to know: Tuesday, October 31, 2017
Virginia Lau
October 31, 2017
2:37 pm

Pfizer Q3 revenue driven by Prevnar sales; President Trump’s opioid panel presents draft to combat crisis; Novartis seeks FDA approval for CAR-T therapy Kymriah

Five things for pharma marketers to know: Monday, June 19, 2017
Five things for pharma marketers to know: Monday, June 19, 2017
Virginia Lau
June 19, 2017
2:37 pm

Adamis receives FDA approval for EpiPen rival Symjepi; Clovis reports positive trial results for ovarian cancer drug Rubraca; hedge fund billionaire John Paulson joins Valeant board of directors

  • Culture drives the company

    Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.

  • From Our Partners